1 Taylor WD, Aizenstein HJ, Alexopoulos GS. Thevascular depression hypothesis:mechanisms linkingvascular disease with depression[J]. Mol Psychiatry,2013, 18:963-974.2 Bi X, Yan B, Fang S, et al. Quetiapine regulatesneurogenesis in ischemic mice by inhibiting NF-kappaBp65/p50 expression[J]. Neurol Res, 2009, 31:159-166.3 M i l l e r A H . N o r m a n C o u s i n s L e c t u r e .Me chanisms of cy tok i ne -i nduced behavior alchanges:psychoneuroimmunology at the translationalinterface[J]. Brain Behav Immun, 2009, 23:149-158.4 Yan B, He J, Xu H, et al. Quetiapine attenuates thedepressive and anxiolytic-like behavioural changesinduced by global cerebral ischemia in mice[J]. BehavBrain Res, 2007, 182:36-41.5 Bi X, Zhang Y, Yan B, et al. Quetiapine preventsoligodendrocyte and myelin loss and promotesmaturation of oligodendrocyte progenitors in thehippocampus of global cerebral ischemia mice[J]. JNeurochem, 2012, 123:14-20.6 Steru L, Chermat R, Thier ry B, et al. The tailsuspension t e s t:a new me t hod for s c r e en i ngantidepressants in mice[J]. Psychopharmacology(Berl), 1985, 85:367-370.7 王维刚, 刘震泽, 吴文婷, 等. 小鼠动物实验方法系列专题(七) 旷场实验在小鼠行为分析中的应用[J]. 中国细胞生物学学报, 2011, 33:1191-1196.8 宋冲, 楚亚楠, 贺桂琼, 等. 梓醇对淀粉样蛋白前体/早老素1双转基因小鼠老年斑和学习记忆的影响[J]. 中 华神经科杂志, 2013, 46:265-268.9 Alexopoulos GS, Morimoto SS. The inflammationhypothesis in geriatric depression[J]. Int J GeriatrPsychiatry, 2011, 26:1109-1118.10 Hannestad J, Dellagioia N, Bloch M. The effectof antidepressant medication treatment on serumlevels of inflammatory cytokines:a meta-analysis[J].Neuropsychopharmacology, 2011, 36:2452-2459.11 Muller N, Schwarz MJ, Dehning S, et al. Thecyclooxygenase-2 inhibitor celecoxib has therapeuticeffects in major depression:results of a double-blind,randomized, placebo controlled, add-on pilot study toreboxetine[J]. Mol Psychiatry, 2006, 11:680-684.12 Tyring S, Gottlieb A, Papp K, et al. Etanerceptand clinical outcomes, fatigue, and depression inpsoriasis:double-blind placebo-controlled randomisedphase III trial[J]. Lancet, 2006, 367:29-35.13 Chen M, Ona VO, Li M, et al. Minocycline inhibitscaspase-1 and caspase-3 expression and delaysmortality in a transgenic mouse model of Huntingtondisease[J]. Nat Med, 2000, 6:797-801.14 Sneed J R, Rindskopf D, Steffens DC, et al. Thevascular depression subtype:evidence of internalvalidity[J]. Biol Psychiatry, 2008, 64:491-497.15 Makhija K, Karunakaran S. The role of inflammatorycytokines on the aetiopathogenesis of depression[J].Aust N Z J Psychiatry, 2013, 47:828-839.16 Sublette ME, Postolache TT. Neuroinflammation anddepression:the role of indoleamine 2, 3-dioxygenase(IDO) as a molecular pathway[J]. Psychosom Med,2012, 74:668-672.17 Zhu CB, Blakely RD, Hewlett WA. The proinflammatorycytokines interleukin-1beta and tumor necrosisfactor-alpha activate serotonin transpor ters[J].Neuropsychopharmacology, 2006, 31:2121-2131.18 Moron JA, Zakharova I, Ferrer JV, et al. Mitogenact ivat ed prot ein kina se reg ulat es dopaminetransporter surface expression and dopamine transportcapacity[J]. J Neurosci, 2003, 23:8480-8488.19 Sheline YI, Pieper CF, Barch DM, et al. Supportfor the vascular depression hypothesis in latelifedepression:results of a 2-site, prospective,antidepressant treatment trial[J]. Arch Gen Psychiatry,2010, 67:277-285. |